Shendelman Shoshana's Form 4 filing
Applied Therapeutics, Inc. (APLT) · filed Aug 14, 2024
- Accession no.
- 0000950170-24-097309
- Filed
- Aug 14, 2024
- Trade date
- Aug 5-14, 2024
- Filing delay
- 9 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions. Open-market sales total $4.71M. It was filed 9 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Shendelman ShoshanaCIK 0001775490 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 5, 2024 | Common Stock | GGiftDisposed | −747,886 | $0.00 | $0 | 0 | Indirect | |
| Aug 5, 2024 | Common Stock | GGiftAcquired | +747,886 | $0.00 | $0 | 747,886 | Indirect | |
| Aug 12, 2024 | Common Stock | SSaleDisposed | −300,000 | $5.98F3 | −$1,794,000 | 5,167,853 | Direct | |
| Aug 13, 2024 | Common Stock | SSaleDisposed | −357,423 | $6.18F4 | −$2,208,874.14 | 4,810,430 | Direct | |
| Aug 14, 2024 | Common Stock | SSaleDisposed | −119,591 | $5.93F5 | −$709,174.63 | 4,690,839 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
Weighted average price. These shares were sold by the reporting person in multiple transactions at prices ranging from $5.57 to $6.205, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Referenced by the price of 1 transaction in Table I.
- F4
Weighted average price. These shares were sold by the reporting person in multiple transactions at prices ranging from $5.82 to $6.39, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Referenced by the price of 1 transaction in Table I.
- F5
Weighted average price. These shares were sold by the reporting person in multiple transactions at prices ranging from $5.825 to $6.265, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Referenced by the price of 1 transaction in Table I.